Occupational Exposure to Carbon Nanotubes and Nanofibers

eport issued on July 22, 2011. NEDO project(P06041) “Research and development of nanoparticlecharacterisation methods.” Japan: New Energyand Industrial Technology Development Organization(NEDO).Golanski L, Guiot A, Rouillon F, Pocachard J, TardifF [2009]. Experimental evaluation of personalprotection devices against graphite nanoaerosols:fibrous filter media, masks, protective clothing, andgloves. Hum Exp Toxicol 28(6–7):353–359.Golanski L, Guiot A, Tardif F [2010]. Experimentalevaluation of individual protection devices againstdifferent types of nanoaerosols: graphite, TiO 2andPt. J Nanopart Res 12(1):83–89.Gregoratto D, Bailey MR, Marsh JW [2010]. Modellingparticle retention in the alveolar-interstitial regionof the human lungs. J Radiol Prot 30(3):491–512.Gregoratto D, Bailey MR, Marsh JW [2011]. Particleclearance in the alveolar-interstitial region ofthe human lungs: model validation. Radiat ProtDosimetry 144(1–4):353–356.Grubek-Jaworska H, Nejman P, Czumińska K,Przybyłowski T, Huczko A, Lange H, BystrzejewskiM, Baranowski P, Chazan R [2006]. Preliminary resultson the pathogenic effects of intratracheal exposureto one-dimensional nanocarbons. Carbon44(6):1057–1063.Han JH, Lee EJ, Lee JH, So KP, Lee YH, Bae GN,Lee S-B, Ji JH, Cho MH, Yu IJ [2008a]. Monitoringmultiwalled carbon nanotube exposure incarbon nanotube research facility. Inhal Toxicol20(8):741–749.Han SG, Andrews R, Gairola G, Bhalia D [2008b].Acute pulmonary effects of combined exposure tocarbon nanotubes and ozone in mice. Inhal Toxicol20(4):391–398.Han SG, Andrews R, Gairola CG [2010]. Acutepulmonary response of mice to multi-wall carbonnanotubes. Inhal Toxicol 22(4):340–347.Harber P, Conlon C, McCunney RJ [2003]. Occupationalmedical surveillance. In: McCunney RJ,ed. A practical approach to occupational and environmentalmedicine. Philadelphia, PA: Lippincott,Williams, and Wilkins.Hinds WC [1999]. Respiratory deposition, Chapter11. In: Hinds WC, ed. Aerosol Technology:Properties, Behavior, and Measurement of AirborneParticles, 2nd edition. New York: J. Wileyand Sons.Hou PX, Liu C, Cheng HM [2008]. Purification ofcarbon nanotubes. Carbon 15(46):2003–3025.Hubbs AF, Mercer RR, Coad JE, Battelli LA, WillardP, Sriram K, Wolfarth M, Castranova V, PorterD [2009]. Persistent pulmonary inflammation,airway mucous metaplasia and migration of multiwalledcarbon nanotubes from the lung after subchronicexposure. The Toxicologist 108:A2193.Hubbs AF, Mercer RR, Benkovic SA, Harkema J,Sriram K, Schwegler-Berry D, Goravanahally MP,Nurkiewicz TR, Castranova V, Sargent LM [2011].Nanotoxicology—a pathologist’s perspective. ToxicolPathol 39(2):301–324.Huczko A, Lange H, Calko E, Grubek-Jaworska H,Droszcz P [2001]. Physiological testing of carbonnanotubes: are they asbestos-like? Fullerene SciTechnol 9(2):251–254.Huczko A, Lange H, Bystrzejewski M, BaranowskiP, Grubek-Jaworska H, Nejman P, Przybyłowski T,Czumińska K, Glapiński J, Walton DRM, KrotoHW [2005]. Pulmonary toxicity of 1-D nanocarbonmaterials. Fullerenes, Nanotubes, and CarbonNanostruct 13(2):141–145.IARC [2010]. IARC monographs on the evaluationof carcinogenic risks to humans: carbon black,titanium dioxide, and talc. Vol. 93. Lyon, France:World Health Organization, International Agencyfor Research on Cancer. Available at: http://monographs.iarc.fr/ENG/Monographs/vol93/index.php.ICRP [1994]. Human respiratory tract model for radiologicalprotection. ICRP publication no. 66. In: SmithH, ed. Annals of the ICRP. Tarrytown, New York: InternationalCommission on Radiological Protection.NIOSH CIB 65 • Carbon Nanotubes and Nanofibers77